1-4 of 4
Peter W. M. Johnson
Close
Sort by
Journal Articles

Comparison of MHG and DZsig reveals shared biology and a core overlap group with inferior prognosis in DLBCL

John R. Davies, Laura K. Hilton, Aixiang Jiang, Sharon Barrans, Catherine Burton, Peter W. M. Johnson, Andrew J. Davies, Ming-Qing Du, Reuben Tooze, Francesco Cucco, Matthew A. Care, Ryan D. Morin, Christian Steidl, Chulin Sha, David R. Westhead, David W. Scott
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6156–6162.
https://doi.org/10.1182/bloodadvances.2023010673
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical impact of ibrutinib plus R-CHOP in untreated DLBCL coexpressing BCL2 and MYC in the phase 3 PHOENIX trial

Clinical Trials & Observations
Peter W. M. Johnson, Sriram Balasubramanian, Brendan Hodkinson, S. Martin Shreeve, Steven Sun, Srimathi Srinivasan, Andrew J. Steele, Jessica Vermeulen, Laurie H. Sehn, Wyndham H. Wilson
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2008–2017.
https://doi.org/10.1182/bloodadvances.2022009389
Published: 2023
Includes: Supplemental data
Journal Articles

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

Thomas E. C. Cummin, Kerry L. Cox, Tom D. Murray, Anna H. Turaj, Lisa Dunning, Vikki L. English, Rachel Fell, Graham Packham, Yan Ma, Ben Powell, Peter W. M. Johnson, Mark S. Cragg, Matthew J. Carter
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3316–3328.
https://doi.org/10.1182/bloodadvances.2020002231
Published: 2020
Includes: Supplemental data
Journal Articles

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma

Clinical Trials & Observations
Tim M. Illidge, Elizabeth H. Phillips, Nicholas Counsell, Ruth Pettengell, Peter W. M. Johnson, Dominic J. Culligan, Bilyana Popova, Laura Clifton-Hadley, Andrew McMillan, Peter Hoskin, Sally F. Barrington, John Radford
Journal: Blood Advances
Blood Adv (2020) 4 (1): 203–206.
https://doi.org/10.1182/bloodadvances.2019001023
Published: 2020
Includes: Supplemental data